Dov A. Goldstein MD, CFO of BioAge Labs Inc. ($BIOA), sold shares on the open market four times over the past year for a total of about $532,000. His latest sale occurred on January 13, 2026. These insider sales rank 6,303rd among 11,678 individuals in our database, compared to an average of $8.6 million per seller across roughly 6.4 transactions. Goldstein made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Common Stock | 3542 | $4.38 | 33,033.0000 | 35,855,037 | 12.01% | 0.01% |
| March 1, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Stock Option (Right to Buy) | 3542 | $0.00 | 159,375.0000 | 35,855,037 | 2.17% | 0.01% |
| Feb. 17, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 35,855,037 | 9999.99% | 0.31% |
| Feb. 1, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Stock Option (Right to Buy) | 3541 | $0.00 | 162,917.0000 | 35,855,037 | 2.13% | 0.01% |
| Feb. 1, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Common Stock | 3541 | $4.38 | 29,491.0000 | 35,855,037 | 13.65% | 0.01% |
| Jan. 16, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Common Stock | 3542 | $4.38 | 25,950.0000 | 35,855,037 | 15.81% | 0.01% |
| Jan. 16, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Stock Option (Right to Buy) | 3542 | $0.00 | 166,458.0000 | 35,855,037 | 2.08% | 0.01% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | S | Common Stock | 8974 | $18.43 | 40,434.0000 | 35,855,037 | 18.16% | 0.03% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Common Stock | 27000 | $8.39 | 49,408.0000 | 35,855,037 | 120.49% | 0.08% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | S | Common Stock | 4440 | $19.45 | 35,994.0000 | 35,855,037 | 10.98% | 0.01% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | S | Common Stock | 11663 | $20.54 | 24,331.0000 | 35,855,037 | 32.40% | 0.03% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | S | Common Stock | 1923 | $21.08 | 22,408.0000 | 35,855,037 | 7.90% | 0.01% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | M | Stock Option (Right to Buy) | 27000 | $0.00 | 92,587.0000 | 35,855,037 | 22.58% | 0.08% |
| Jan. 2, 2026 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Aug. 18, 2025 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Director | M | Stock Option (right to buy) | 17557 | $0.00 | 0.0000 | 16,724,998 | 100.00% | 0.10% |
| Aug. 18, 2025 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Director | M | Common Stock, par value $0.0001 per share | 17557 | $1.09 | 27,557.0000 | 16,724,998 | 175.57% | 0.10% |
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | GOLDSTEIN DOV A MD | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| Feb. 25, 2025 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2025 | BioAge Labs, Inc. | $BIOA | GOLDSTEIN DOV A MD | Chief Financial Officer | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | GOLDSTEIN DOV A MD | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| Jan. 1, 2024 | Coya Therapeutics, Inc. | $COYA | GOLDSTEIN DOV A MD | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | GOLDSTEIN DOV A MD | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |